بسم الله الرحمن الرحیم.

Slides:



Advertisements
Similar presentations
Approach to child with purpura
Advertisements

Heather D. Mannuel, MD, MBA March 12, 2008
Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Normocytic Anemia Dr. Fatin Al-Sayes, MD, MSc, MRCPath Consultant Hematology / Assistant Professor King Abdulaziz University Hospital.
Michael F. McNamara, DO Sanford Maternal Fetal Medicine.
Hemorrhagic diseases. Lesions of the blood vessels Lesions of the blood vessels Abnormal platelets Abnormal platelets Abnormalities in the coagulation.
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA Noel K Strong MD Maternal Fetal Medicine The Icahn School of Medicine at Mount Sinai.
Bleeding disorders Doc. MUDr. L. Boudová, Ph.D.. Bleeding disorders I. Vessels - increased fragility II. Platelets - deficiency or dysfunction III.Coagulation.
BLEEDING DISORDERS AN OVERVIEW WITH EMPHASIS ON EMERGENCIES.
Neonatal Thrombocytopenia
Thrombocytopenia in SGA Neonates Israel Neonatology AssociationRobert Christensen, MD.
Aplastic Anemia Rakesh Biswas
PLATELETS. PLETELET PHYSIOLOGY Platelets Production: Hematopoietic stem cell  Megakaryoblast  Megakaryocyte  Fragmentation of cytoplasm Platelets.
Hemostatic System - general information Normal hemostatic system –vessel wall –circulating blood platelets –blood coagulation and fibrynolysis Platelets.
KANUPRIYA CHATURVEDI 1.  1. Explain the relationship between platelet count and bleeding risk.  2. State the underlying pathologic mechanisms that may.
Neonatal Thrombocytopenia Stacie Bennett, M.D. East Bay Newborn Specialists.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Thrombocytopenia Rahul Gladwin, MS3
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
IMMUNE THROMBOCYTOPENIA Cathy Payne MSN, ACNP-BC Hematology/Oncology Nurse Practitioner Ironwood Cancer and Research Centers.
Polycythemia Group C: Melanie, Michele, Sarah.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
1 Disseminated Intravascular Coagulation Paramedic Program Chemeketa Community College.
Sue Ann Smith, MD Neonatologist Doernbecher Neonatal Care Center
ITP Immune (Idiopathic) Thrombocytopenic Purpura AM Report 5/25/2010.
بسم الله الرحمن الرحـيـم
Approach to the newborn with thrombocytopenia Dr. Lourdes Asiain Nov 2004.
A newborn with petechiae. HPI Newborn male born to 34 y/o G9P2253 mother at 37 weeks via C/S Maternal history: endometriosis, h/o molar pregnancy, anemia,
THROMBOCYTOPENIA - reduced platelet count -. First of all.. what are platelets? Platelets: tiny cells that circulate in the blood and whose function is.
Salwa Hindawi. MSc, MRCPath, CTM RCPE Director of Blood Transfusion Services King Abdulaziz University Hospital Jeddah, Saudi Arabia.
Approach to patient with cytopenias
Autoimmune Idiopathic Thrombocytopenic Purpura (ITP) Nicola Davis.
By Fatin Al-Sayes MD, MSc, FRCPath Consultant Hematology Assistant Professor.
Thrombocytopenia Dr S W Bokhari Consultant Haematologist University Hospital Coventry and Warwickshire.
Splenectomy in Hematologic Disorders
HIV and haematology Mike Webb Division of Clinical Haematology 5 March 2011.
Aplastic anemia. Definition Panctopenia with hypocellularity A rare and serious condition, aplastic anemia can develop at any age, though it's most common.
APLASTIC ANEMIA.
Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated.
HIV and haematology Mike Webb Division of Clinical Haematology 8 Feb 2010.
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
ANAEMIA Outi Vehviläinen, MD Ilembula
Hemostatic process 1- Vascular Consrriction 2- Platelet plug formation 3- Fibrin formation ( Coagulation ) 4- Fibrinolysis.
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
CBC Basic Interpretation Tanim I. Aziz, MBBS. CBC… is one of the most common laboratory tests in medicine. Typically, it includes the following: White.
Thrombocytopenia Sheryl L. Ziegler, D.O Hemostasis Subendothelial matrix Platelets Hemostatic plug Fibrin Endothelial cell RBC WBC WBC.
APLASTIC ANEMIA Divisi Hemato-Onkologi Bagian Ilmu Kesehatan Anak Universitas Sumatera Utara.
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Types of Apheresis Blood taken from a healthy donor can be separated into its component parts during blood donation, where the needed component is collected.
Acquired Hemolytic Anemias
THROMBOCYTOPENIA Reduction in platelet count below 150 x 109
The CBC Mystique Clinical Pearls for Primary Care ARNPs
Anemia of Chronic Disease
Bleeding disorders due to vascular & platelets abnormalities
NEONATAL IMMUNE THROMBOCYTOPENIA
MLAB 1415-Hematology Keri Brophy-Martinez
Thrombocytopenia Allen Chang, PGY2 5/18/15.
Approach to the newborn with thrombocytopenia
MLAB 1415-Hematology Keri Brophy-Martinez
Platelets disorders.
January 2018 Jason aboudi mouabbi MD
Approach to Thrombocytopenia
platelet function:    1- Adhesion — the deposition of platelets on the .
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Disseminated Intravascular Coagulation
The Fascinating World of Haemostasis and Thrombosis
How I treat thrombocytopenia in pregnancy
Thrombocytopenia in pregnancy
Presentation transcript:

بسم الله الرحمن الرحیم

NEONATAL THROMBOCYTOPENIA

NEONATAL THROMBOCYTOPENIA <150,000/microL Term , preterm

The 5th percentile was lower than the standard adult value and decreased with decreasing GA.

100,000 to 150,000/microL  Mild 50,000 to 99,000/microL  Moderate <50,000/microL Severe

In SGA infants: 31% had platelet <150,000/microL 10% (3 In SGA infants: 31% had platelet  <150,000/microL 10% (3.5 % of all) had a recognized cause (DIC,…) with a high mortality rate (65%)

APPROACH TO NEONATAL THROMBOCYTOPENIA

Time of presentation 1- Fetal 2- Early (< 72 h.) 3- Late (< 72 h.)

Fetal : - Mainly TORCH - Alloimmune Condition -Autoimmune condition (e Fetal : - Mainly TORCH - Alloimmune Condition -Autoimmune condition (e.g.,ITP, SLE) - Aneuploidy (Trisomy 13, 18 & 21) - Congenital/Inherited (Wiskoot-Aldrich syn.)

Early-onset neonatal(72h) - Placental insufficiency (IUGR,diabetes) - Perinatal asphyxia - Alloimmune condition -Autoimmune condition (e.g.,ITP, SLE) - Thrombosis( e.g.,renal vein, aortic) - Metabolic disease(proprionic and methylmalonic acidemia) - Bone marrow replacement ( congenital leukemia) - Congenital infection(CMV, Toxo, HIV) - Congenital/inherited (e.g.,TAR, CAMT) - Kasabach-Merritt syndrome

Late-onset neonatal(>72h) - Late-onset sepsis - NEC - Congenital infection (e.g., CMV, toxo, rubella, HIV) - Autoimmune - Kasabach-Merritt syndrome - Metabolic disease(proprionic and methylmalonic acidemia) - Congenital/inherited (e.g.,TAR, CAMT)

Decreased Production: Marrow hypoplasia -viral infections (TORCH,HIV) Bon Marrow Failure - Fanconi’s anemia Idiopathic aplastic anemia Drug-induced Marrow infiltration - Lukemia Familial -macro thrombocytopenia, Alport’s syn

Increaed Consumtion:. Immune Mechanisms:. - ITP. - Alloimmune Increaed Consumtion: Immune Mechanisms: - ITP - Alloimmune - Drug- assosiated Coagulation activation - DIC Mechanical pooling - Hypersplenism Thrombotic microangiopathies -HUS - TTP

History: - Onset - Clinical examination. - Organomegaly History: - Onset - Clinical examination - Organomegaly - Joint or soft tissue bleeding - Ischemic limb, necrosis - Recent transfusion

Drugs and thrombocytopenia: Acetaminophen Amphotericin B Carbamezapine Chlorpropamide Cimetidine Danazol Hydrochlorothiazide Interferon-α Methyldopa Nalidixic Acid Phenytoine Quinidine Ranitidine Rifampin Trimethoprim/sulfamethoxazole Vancomycin

Morphologic aspect of PBS: Large: macrothrombocytopenia Large + Normal size: peripheral distruction Normal size: reduced production Small: Wiskott-Aldrich syn. Variable size: myelodysplastic syn.

Mean platelet volume (MPV) average size of circulating platelets Normal (7.5–9.5 fL): reduced production Elevated (10–12 fL): accelerated destruction

Reticulated platelets: Newly produced platelets having a higher ribonucleic acid content than do older platelets

RP% is low (< 2%): Low platelet production & high(> 10%): platelets are being consumed